Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA · Real-Time Price · USD
33.07
+1.30 (4.09%)
At close: Nov 20, 2026, 4:00 PM EST
33.30
+0.23 (0.70%)
After-hours: Nov 20, 2026, 7:30 PM EST
Lycia Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The platformâs three Phase I programs target IgE-mediated disease and Gravesâ disease. Initial 70 mg LCA-0061 data showed 96% mean maximum reductions in total and free IgE; further program data are planned for 2027.